| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |